by [150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global healthcare BPO market was valued at around USD 334.15 billion in 2021 and is expected to register revenues worth USD 755.76 billion by the end of 2030, growing at an exceptional CAGR of approximately 9.49% between 2022 and 2030.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/2014
Healthcare BPO Market Report Scope
A recent study by Precedence Research on the healthcare BPO market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the healthcare BPO market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of healthcare BPO. The study also provides the dynamics that are responsible for influencing the future status of the healthcare BPO market over the forecast period.
A detailed assessment of the healthcare BPO market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the healthcare BPO market along with their product portfolio enhances the reliability of this comprehensive research study.
Competition Landscape
The report has engulfed a chapter on the global healthcare BPO market’s competitive landscape, which provides detailed analysis and insights on companies offering healthcare BPO. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.
This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.
Read Also@ Home Infusion Therapy Market Size to Worth Around US$ 65.2 Billion by 2030
Some of the Prominent Players in the Healthcare BPO Market Include:
- Accenture (Ireland)
- Access Healthcare (US)
- Akurate Management Solutions (US)
- Cognizant (US)
- Firstsource Solutions (India)
- GeBBS Healthcare Solutions (US)
- Genpact (US)
- HCL Technologies (India)
- IBM Corporation (US)
- Infosys BPM (India)
- Invensis Technologies (India)
- IQVIA (US)
- Lonza (Switzerland)
- Mphasis (India)
- NTT Data Corporation (Japan)
- Omega Healthcare (India)
- Parexel International (US)
- R1 RCM (US)
- Sutherland Global (US)
- Sykes Enterprises (US)
- Tata Consultancy Services (India)
- UnitedHealth Group (US)
- Wipro (India)
- WNS (Holdings) Limited (India)
- Xerox Corporation (US)
Healthcare BPO Market Segmentation
By Provider Service
- Revenue Cycle Management
- Patient Enrolments
- Patient Care
- Medical Transcription
- Medical Imaging
- Device Monitoring
By Payer Service
- Claims Management
- Claims Adjudication Services
- Claims Settlement Services
- Information Management Services
- Claims Repricing
- Claims Investigation Services
- Claims Indexing Services
- Fraud Detection & Management
- Product Development & Business Acquisition (PDBA)
- Member Management
- Provider Management
- Care Management
- Integrated Front-End Services and Back-office Operations
- Billing and accounts management services
- HR Services
By Life Science Service
- Manufacturing
- R&D
- Non-Clinical Services
- Supply Chain Management & Logistics
- Sales and Marketing Services
- Forecasting
- Performance Reporting
- Analytics
- Research
- Marketing
- Other Non-Clinical Services
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Regional Analysis
The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
The report provides in-depth segment analysis of the global healthcare BPO market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the healthcare BPO market.
The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.
Why should you invest in this report?
If you are aiming to enter the global healthcare BPO market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for healthcare BPO are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare BPO Market
5.1. COVID-19 Landscape: Healthcare BPO Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare BPO Market, By Provider Service
8.1. Healthcare BPO Market, by Provider Service, 2022-2030
8.1.1 Revenue Cycle Management
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Patient Enrolments
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Patient Care
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare BPO Market, By Payer Service
9.1. Healthcare BPO Market, by Payer Service, 2022-2030
9.1.1. Claims Management
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Product Development & Business Acquisition (PDBA)
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Member Management
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Provider Management
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Care Management
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Integrated Front-End Services and Back-office Operations
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Billing and accounts management services
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.8. HR Services
9.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Healthcare BPO Market, By Life Science Service
10.1. Healthcare BPO Market, by Life Science Service, 2022-2030
10.1.1. Manufacturing
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. R&D
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Non-Clinical Services
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Healthcare BPO Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.1.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.1.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Provider Service (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Payer Service (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Life Science Service (2017-2030)
Chapter 12. Company Profiles
12.1. Accenture (Ireland)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Access Healthcare (US)
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Akurate Management Solutions (US)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cognizant (US)
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Firstsource Solutions (India)
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GeBBS Healthcare Solutions (US)
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Genpact (US)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. HCL Technologies (India)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. IBM Corporation (US)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Infosys BPM (India)
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/2014
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
